바로가기메뉴

본문 바로가기 주메뉴 바로가기

Tuberculosis & Respiratory Diseases

Article Contents

Prev Next
e-Submission

Vol.66 No.3
Citation Share

Prevalence and Risk Factors of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2009, v.66 no.3, pp.186-191





& (2009). Prevalence and Risk Factors of Osteoporosis in Patients with Chronic Obstructive Pulmonary Disease. Tuberculosis & Respiratory Diseases, 66(3), 186-191.
  • Downloaded
  • Viewed
PDF Download

Abstract

Background: Osteoporosis is a significant comorbidity in patients with chronic obstructive pulmonary disease(COPD). This study examined the prevalence and risk factors associated with osteoporosis in patients with COPD. Methods: The bone mineral densities (BMDs) of the lumbar spine and femoral bone were measured in 53 patients with clinically stable COPD and 41 age- and gender-matched control subjects showing a normal lung function. Osteoporosis was defined as a T-score ≤−2.5. The subjects’ clinical characteristics and laboratory data were reviewed, and multiple logistic regression analysis was used to identify the risk factors associated with osteoporosis in COPD patients. Results: The prevalence of osteoporosis was 47% and 32% in the COPD patients and controls, respectively. In particular, using the femoral neck T-score, the prevalence of osteoporosis in COPD patients was higher than that in the controls (26% vs. 5%; p=0.006). The average T-score of the lumbar spine (p=0.025) and femoral neck of COPD patients were significantly lower than those of the controls (p=0.001). The forced expiratory volume in the 1 second (FEV1) % predicted (p=0.019; odds ratio [OR], 0.955; 95% confidence interval [CI], 0.919-0.993) and age (p=0.024; OR, 1.144; 95% CI, 1.018-1.287) were independently associated with osteoporosis in patients with COPD. Conclusion: Using the femoral neck T-score, the prevalence of osteoporosis in patients with COPD was higher than the age-and gender-matched controls. A lower FEV1 and older age further increase the risk of osteoporosis in patients with COPD.

keywords
Chronic obstructive pulmonary disease, Osteoporosis, Prevalence, Risk factor, Lung function

Reference

1.

Chatila WM, Thomashow BM, Minai OA, Criner GJ, Make BJ. Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5:549-55.

2.

Incalzi RA, Caradonna P, Ranieri P, Basso S, Fuso L, Pagano F, et al. Correlates of osteoporosis in chronic obstructive pulmonary disease. Respir Med 2000;94:1079-84.

3.

Iqbal F, Michaelson J, Thaler L, Rubin J, Roman J, Nanes MS. Declining bone mass in men with chronic pulmonary disease: contribution of glucocorticoid treatment, body mass index, and gonadal function. Chest 1999;116:1616-24.

4.

Shane E, Silverberg SJ, Donovan D, Papadopoulos A, Staron RB, Addesso V, et al. Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med 1996;101:262-9.

5.

Block JE, Stubbs H. Hip fracture-associated mortality reconsidered. Calcif Tissue Int 1997;61:84.

6.

Biskobing DM. COPD and osteoporosis. Chest 2002;121:609-20.

7.

Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76.

8.

American Thoracic Society. Standardization of Spirometry, 1994 Update. Am J Respir Crit Care Med 1995;152:1107-36.

9.

Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137-41.

10.

Jϕ rgensen NR, Schwarz P, Holme I, Henriksen BM, Petersen LJ, Backer V. The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med 2007;101:177-85.

11.

Slemenda CW, Hui SL, Longcope C, Johnston CC Jr. Cigarette smoking, obesity, and bone mass. J Bone Miner Res 1989;4:737-41.

12.

Daniell HW. Osteoporosis and smoking. JAMA 1972;221:509.

13.

Bassett CA, Becker RO. Generation of electric potentials by bone in response to mechanical stress. Science 1962;137:1063-4.

14.

Cauley JA, Salamone LM, Lucas FL. Postmenopausal endogenous and exogenous hormones, degree of obesity, thiazide diuretics, and risk of osteoporosis. In: Marcus R, Feldman D, Kelsey J, editors. Osteoporosis. 1st ed. New York: Academic Press; 1996. p. 551-76.

15.

Adachi JD. Corticosteroid-induced osteoporosis. Am J Med Sci 1997;313:41-9.

16.

Lane NE, Lukert B. The science and therapy of glucocorticoid- induced bone loss. Endocrinol Metab Clin North Am 1998;27:465-83.

17.

Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 1996;81:3441-7.

18.

Sevenoaks MJ, Stockley RA. Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype? Respir Res 2006;7:70.

19.

Dalsky GP, Stocke KS, Ehsani AA, Slatopolsky E, Lee WC, Birge SJ Jr. Weight-bearing exercise training and lumbar bone mineral content in postmenopausal women. Ann Intern Med 1988;108:824-8.

20.

White MK, Martin RB, Yeater RA, Butcher RL, Radin EL. The effects of exercise on the bones of postmenopausal women. Int Orthop 1984;7:209-14.

21.

Choi JS, An KC, Lee CS, Choi JM, Kim JY, Shin DR. DEXA T-score concordance and discordance between hip and lumbar spine. J Korean Soc Spine Surg 2003;10:75-81.

Tuberculosis & Respiratory Diseases

e-Submission OA Policy